Place/Date: London, United Kingdom - August 18th, 2020 at 11:17 am UTC · 3 min read
Contact: Sean Flanagan, Source: ClinTex
With the current global pandemic sweeping the globe, the fiscal impact can be seen everywhere, and in industries once considered safe havens, impacts expected to last a decade are commonplace. From the tech moguls of Silicon Valley, to the high-tech production centers of Europe, It is clear that the world is crying out for innovation in a time where opportunities are few and far between.
To this end, London-based company ClinTex says it has the answer to a disempowered financial ecosystem. It looks perfectly poised to provide a solution not only to medical patients worldwide, but the healthcare industry as a whole and of course, to provide a potentially amazing return to its stakeholders through its CTi token pre-sale, which is currently ongoing.
The value proposition for ClinTex lies in one simple observed fact – for an industry that is considered cutting edge, the Pharmaceutical industry is fraught with inefficiency. In such a notable time for health globally, these inefficiencies are having widespread consequences:
With the current pandemic raging on, and 142 COVID-19 vaccines currently awaiting trials, there has never been a better time for CTi’s implementation in the industry. We are already seeing haphazard attempts at research collaboration in the hunt for a COVID-19 vaccine and treatments. And with these spends potentially reaching into the trillions, CTi could represent the next generation of innovative profits to follow DeFi in re-igniting the crypto wave not seen since the ICO boom of 2017.
The CTi token pre-sale runs until 25th September 2020, and CTi can be purchased for a 50% discounted price of 0.05$ by visiting this link. $1m USD in CTi is available for purchase, which is equivalent to 10% of the total CTi supply. Leftover tokens will be burned, and the main sale commences in October 2020 where tokens will be available for $0.10.
ClinTex is doing what all companies strive to do in times of hardship – To innovate. And with a market valued at $350,000,000,000 per year, the possibilities are endless. Now is the time. Be a part of this exciting project and enjoy discounts on one of the industry’s most promising projects this year.
Disclaimer: ClinTex is the source of this content. This press release is for informational purposes only. The information does not constitute investment advice or an offer to invest. The ClinTex token sale is closed to US participants and participants of all countries in which ICO/IEOs are illegal. Virtual currency is not legal tender, is not backed by the government, and accounts and value balances are not subject to consumer protections. Token sales are only suitable for individuals with a high risk tolerance. Only participate in a token event with what you can afford to lose.